CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 94 filers reported holding CUE BIOPHARMA INC in Q3 2020. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $308,000 | -49.5% | 20,500 | -17.7% | 0.00% | -66.7% |
| Q2 2020 | $610,000 | +52.5% | 24,900 | -11.7% | 0.00% | +50.0% |
| Q1 2020 | $400,000 | -10.5% | 28,200 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $447,000 | -5.7% | 28,200 | -50.0% | 0.00% | +100.0% |
| Q3 2019 | $474,000 | +253.7% | 56,400 | +276.0% | 0.00% | 0.0% |
| Q2 2019 | $134,000 | +605.3% | 15,000 | +500.0% | 0.00% | – |
| Q1 2019 | $19,000 | +72.7% | 2,500 | 0.0% | 0.00% | – |
| Q4 2018 | $11,000 | -50.0% | 2,500 | 0.0% | 0.00% | – |
| Q3 2018 | $22,000 | -24.1% | 2,500 | 0.0% | 0.00% | – |
| Q2 2018 | $29,000 | -17.1% | 2,500 | 0.0% | 0.00% | – |
| Q1 2018 | $35,000 | – | 2,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,545,573 | $3,447,000 | 1.85% |
| P.A.W. CAPITAL CORP | 200,000 | $446,000 | 0.67% |
| SANDERS MORRIS HARRIS LLC | 848,048 | $2,020,000 | 0.50% |
| Monaco Asset Management SAM | 458,851 | $1,023,000 | 0.39% |
| Bleichroeder LP | 555,000 | $1,238,000 | 0.26% |
| APOGEM CAPITAL LLC | 110,614 | $247,000 | 0.25% |
| Slate Path Capital LP | 1,483,619 | $3,308,000 | 0.22% |
| Voss Capital, LLC | 200,000 | $446,000 | 0.13% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $1,067,000 | 0.11% |
| CARLSON CAPITAL L P | 535,000 | $1,193,000 | 0.09% |